Puzzlingly, in addition to executing its anti-tumor effects through BRCA1, KSR1 negatively regulates transcriptional activity of p53 by reducing p53 acetylation via modulation of deleted in breast cancer 1 (DBC1) phosphorylation [7]. This evidence concerns the gene TP53 and neoplasm.